GeneOne Life Science Inc (011000) — Free Cash Flow Generation Index

Latest as of December 2021: -8.66x

GeneOne Life Science Inc (011000) has a Free Cash Flow Generation Index of -8.66x as of December 2021. Free cash flow of ₩-31.74 Billion represents -9% of operating cash flow (₩3.67 Billion). See GeneOne Life Science Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

-8.66x
Free Cash Flow / Operating CF

Free Cash Flow

₩-31.74 Billion
KRW

Operating Cash Flow

₩3.67 Billion
KRW

Capital Expenditures

₩35.40 Billion
KRW

GeneOne Life Science Inc Free Cash Flow Generation Index (2015–2015)

Historical FCF Generation Index trend for GeneOne Life Science Inc across 1 annual periods. Explore GeneOne Life Science Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for GeneOne Life Science Inc (2015–2015)

Year-by-year Free Cash Flow Generation Index for GeneOne Life Science Inc. For the full company profile including market capitalisation, see GeneOne Life Science Inc stock valuation.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2015 3.62x ₩2.82 Billion ₩778.50 Million ₩2.04 Billion —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).